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LimoneneThe traditional use of essential oils in aromatherapy has offered numerous health beneﬁts. However, few
scientiﬁc studies have been conducted with these oils to conﬁrm their therapeutic efﬁcacy. (+)-Limonene
is a chemical constituent of various bioactive essential oils. The present study reports on the anxiolytic-like
effects of (+)-limonene in an elevated maze model of anxiety in mice. At concentrations of 0.5% and 1.0%,
(+)-limonene, administered to mice by inhalation, signiﬁcantly modiﬁed all the parameters evaluated in
the elevated plus maze test. The pharmacological effect of inhaled (+)-limonene (1%) was not blocked by
ﬂumazenil. Analysis of (+)-limonene using gas chromatography–mass spectrometry (GC–MS) showed its
volatility to be high. These data suggest possible connections between the volatility of (+)-limonene and
its anxiolytic-like effect on the parameters evaluated in the elevated plus maze test. The data indicate that
(+)-limonene could be used in aromatherapy as an antianxiety agent.
© 2012 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
The therapeutic effects of essential oils in physical and psycholog-
ical disorders are well known. In fact, aromatherapy studies have
reported the medicinal properties of aromas that have been used for
thousands of years by humans to promote well-being and treat vari-
ous diseases. The aromas of essential oils, administered via inhalation,
exert an effect on the brain, resulting in behavioral changes in ani-
mals and humans (Lawless, 2002). Their use as psychoactive drugs
represents an alternative method of treating behavioral alterations,
such as anxiety, that undermine the health of human beings. Indeed,
the relaxing effect of essential oils has stimulated the interest of both
investigators and lay users who traditionally administer these prod-
ucts by inhalation with the objective of restoring health. They may
represent an alternative to synthetic drugs. For example, rose andaraíba, Caixa Postal 5009, CEP
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vier OA license. lavender oils have been reported to induce anxiolytic-like effects
when administered by inhalation to animals (Almeida et al., 2004;
Shaw et al., 2007). Chemical constituents of essential oils also present
psychoactive properties, as is the case with monoterpene linalool,
which is found in rose and lavender oils. Some studies involving
these essential oils found anxiolytic-like effects in mice following in-
halation of linalool (Linck et al., 2010). Another study evaluated inha-
lations of (R)-(−)- and (S)-(+)-linalool by human subjects under
experimental stress and conﬁrmed that both linalool enantiomers
exert a relaxing effect (Höferl et al., 2006).
The anxiolytic-like properties of Citrus essential oils such as that
found in Citrus aurantium L., suggested by traditional use, have been
demonstrated in mice (Carvalho-Freitas and Costa, 2002; Pultrini et
al., 2006). The anxiolytic-like effects of sweet orange aroma have been
shown inWistar rats (Faturi et al., 2010). Interestingly, this oil is plenti-
ful and can be easily obtained, particularly in orange-producing coun-
tries such as Brazil. The major chemical component (96.24%) of this
oil is the monoterpene limonene (Leite et al., 2008), which is also pres-
ent in high proportions in other citrus fruits and is marketed by many
manufacturers of essential oils (Malhotra et al., 2009).
Although the chemical components of essential oils are capable of
acting together to induce the pharmacological effect, (+)-limonene
may constitute the principal active ingredient of orange aroma due
to its high percentage in orange essential oil. Therefore, in light of
these facts and the lack of previous reports on the anxiolytic activity
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potential of (+)-limonene administered to mice by inhalation.
2. Materials and methods
2.1. Animals
Male Swiss (Mus musculus) albino mice (25–35 g) obtained from
the Prof. Dr. Thomas George vivarium facility at the Pharmaceutical
Technology Laboratory of the Federal University of Paraíba were
used in this study. Animals were kept in polypropylene boxes covered
with sawdust, at controlled temperature (21±1 °C), with 12-hour
light/dark cycles (lights on at 6 am, lights off at 6 pm). Food (Purina®
pellets) and water were provided ad libitum until 1 h prior to the ex-
perimental procedures. All the experiments were carried out between
11 am and 4 pm. All the experimental protocols and procedures were
approved by the Animal Experimentation Ethics Committee (CEPA)/
LTF (#0605/07).
2.2. Drugs and treatments
(R)-(+)-Limonene (97% purity) was purchased from company
Dierberger Óleos Essenciais S.A., Barra Bonita, Brazil and was diluted
with polyoxyethylene sorbitan monooleate (Tween 80 [VETEC,
Brazil], 0.2% v/v in distilled water) to prepare (R)-(+)-limonene
emulsions (0.5%, 1.0% and 2.5%) minutes before the experiments.
Diazepam (Merck, Brazil) was dissolved in saline and used as a posi-
tive control (1 mg/kg), administered intraperitoneally at a volume of
0.1 mL/10 g body weight. Flumazenil (Cristália, Brazil) was dissolved
in saline and used as a benzodiazepine receptor antagonist (10 mg/kg),
also administered intraperitoneally. Negative control groups were
given inhalations of 0.2% Tween 80 or intraperitoneal injections of
saline.
2.3. Inhalation apparatus
The inhalation apparatus consisted of an acrylic box (36×30×29 cm)
with a stainless steel grid ﬂoor onto which the animals were individually
placed. The front and back walls contained four holes (each 2 cm in di-
ameter) where drug-embedded cotton balls were placed, containing
2.5 mL per unit of the respective substance [saline or (R)-(+)-limonene
emulsion]. The topwall contained 30 small holes for ventilation. Based on
previous studies conducted by Almeida et al. (2004), the duration of
exposure to the drug (limonene or saline solution) was established at
7 min. After each exposure session, it was conducted the cleaning of
apparatus and the cotton wool containing (R)-(+)-limonene was
replaced to maintain the concentration of the drug in the apparatus.
2.4. Elevated plus maze test
The elevated plus maze (EPM) test was ﬁrst developed for rats
(Pellow et al., 1985) and later adapted for mice (Lister, 1987). The
test uses openness combined with elevation to generate behavioral
changes predominantly related to anxiety (Schmitt and Hiemke,
1998). It is based on the anxiety-related behavior of rodents and the
animals' predisposition toward dark, enclosed spaces and an uncon-
ditioned fear of heights and open spaces (Bradley et al., 2007). The
apparatus was made of gray acrylic material (Insight®, São Paulo,
Brazil) and consisted of two open arms (30 cm×5 cm×15 cm) and
two enclosed arms (30 cm×5 cm×15 cm) radiating from a central
platform (5×5 cm) to form a plus (+) sign.
The apparatus was elevated to a height of 38.5 cm and placed
inside a sound-attenuated room. The trial began by placing an animal
on the central platform of the maze facing an open arm 30 min after
i.p. administration or 7 min after inhalation of (R)-(+)-limonene or
vehicle. The number of entries and the time spent in the open armsof the device were counted during a 5-minute test period. The animal
was considered to have entered into an arm only when all four paws
were in that arm (Biala and Kruk, 2008).
Combinations of ﬂumazenil (FLU) with (R)-(+)-limonene or diaze-
pam (DZP) were administered to the mice, which were divided into
eight groups of eight animals each and treated with vehicle; FLU
(10 mg/kg), DZP (1 mg/kg), FLU (10 mg/kg)+DZP (1 mg/kg); (R)-
(+)-limonene (0.5%, 1.0%, 2.5%) or FLU (10 mg/kg)+(R)-(+)-
limonene (1%), respectively.2.5. Analytical methodology
2.5.1. Linearity curves
The ﬁrst linear curve was constructed from the peak versus the
range in the concentration of limonene (0.17 to 0.51 μg/mL). A sec-
ond linear curve was obtained using the estimated concentration of
the samples versus the time at which the sample was collected. Linear
regression was calculated using the least-squares method with a cor-
relation coefﬁcient (R2) ≥0.99.2.5.2. Sample analysis
Fifty microliter of (+)-limonene was injected into a hole at the
center of an enclosed system measuring 36.5 cm×28.5 cm×31 cm.
Next, after an initial saturation period, aliquots of 10 μl were collected
from the atmosphere within the gaseous system at the following time
points: 13 min, 23 min and 33 min, and then analyzed using gas
chromatography–mass spectrometry (GC–MS).
GC–MS analysis was performed in a Shimadzu GC–MS-QP5050A—
GC/MS system (EI mode 70 eV, source temperature 250 °C, scan
range 45–450 amu). The operating conditions were as follows: a cap-
illary column with a stationary phase of 5% phenyl- and 95%
dimethylpolysiloxane (J & W Scientiﬁc, 30 m×0.25 mm i.d.×
0.25 μm ﬁlm thickness); helium as the carrier gas, ﬂow rate of
1.5 mL min−1 and split ratio of 1:5; from 70 °C (2 min) to 105 °C at
8 °C/min and then to 250 °C at 40 °C/min, with a ﬁnal hold of 9 min
at 250 °C.
The compound was identiﬁed by comparing GC retention index
relative to n-alkanes (C8–C20) as well as by comparing its mass spec-
tra with the Wiley 275.L database (Wiley/NBS library).2.6. Statistical analysis
The data obtained were evaluated using analysis of variance
(ANOVA) followed by the Bonferroni multiple comparison test. Data
were analyzed using the GraphPad Prism software package (version
5.0) with the experimental groups being compared with the vehicle
group. p-Valuesb0.05 were considered statistically signiﬁcant.3. Results
3.1. Gas chromatography analysis of the concentration of limonene at
different moments
The data of peak areas versus standard limonene concentration will
allow the linear equation: y=144098x−137498 with r2 0.9996 to be
obtained. The limonene concentrations in the samples were calculated
from the linear equation for the sampling times of 13, 23 and 33 min
(Table 1).
The data from the limonene concentration samples versus sampling
time were used to obtain the linear equation: y=0.1895x+1.3915
with r2 0.9940. The limonene concentrations at 7 and 14 min were
calculated from the linear equation, resulting in ﬁndings of 2.72 and
4.04 μg/cm3 of air, respectively.
Table 1
Analytical parameters of the kinetics of dispersion of (+)-limonene.
Sampling points Analytical parameters
Time of collection Area Conc. (μg/cm3)
LT2 13 min 405,586 3.77
LT3 23 min 714,868 5.92
LT4 33 min 952,220 7.56
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The data illustrated in Fig. 1 show that inhalation of (+)-limonene
(0.5% and 1.0%) and the intraperitoneal administration of diazepam
resulted in an increase in the number of open arm entries compared
to the respective control groups (pb0.05, F=4.9). As shown in
Fig. 2, the time spent in the open arms of the device was also signiﬁ-
cantly affected by (+)-limonene (0.5% and 1.0%) and diazepam
(pb0.05 and pb0.01; F=6.1).
The effect of (+)-limonene (1.0%) on the number and duration of
open arm entries in the elevated plus maze test was not altered by
ﬂumazenil with pb0.001 and F=21.2 and 13.1, respectively. On the
other hand, ﬂumazenil blocked the effect of diazepam (1 mg/kg)
with regards to the number of open arm entries and the time spent
in the open arms. Signiﬁcant results were not observed for the num-
ber of entries and time spent in closed arms in both tests.
4. Discussion
Many essential oils have relaxing properties and have long been
used traditionally in folk medicine (Lawless, 2002). However, few
studies have been conducted using standardized methodology to dem-
onstrate the anxiolytic-like effects of these fragrances when adminis-
tered by inhalation, as in aromatherapy. Therefore, the present study
investigated the effects of (+)-limonene aromaonmice using standard-
ized inhalation procedures. In addition, the pharmacological data were
correlated with volatility data obtained by gas chromatography–mass
spectroscopy.0
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Fig. 1. Effect of (+)-limonene on the time spent on open (a) and closed (c) arms (s) and on
ferent concentrations of inhaled (+)-limonene and diazepam i.p. in male mice. Data are exp
limonene, DZP = diazepam, INH = inhalation route, I.P. = intraperitoneal route.The effect of (+)-limonene was examined in an elevated plus
maze model of anxiety in mice. Inhalations of (+)-limonene at con-
centrations of 0.5 or 1.0% increased the number of times the animals
entered the open arms of the maze. Interestingly, this behavior was
not observed at a concentration of 2.5% (Fig. 1). At concentrations of
0.5 and 1% (+)-limonene also increased the amount of time the ani-
mals spent in the open arms of the maze. Again, this behavior was not
observed at a concentration of 2.5% (Fig. 2). This negative result could
perhaps be attributed to a day effect associated with animal variabil-
ity. Similar results have been found with other components of essen-
tial oils such as in the recent study conducted with linalool oxide
(Souto-Maior et al., 2011). (+)-Limonene was found to exert an anxi-
olytic effect similar to that seen with diazepam (1 mg/kg, i.p.), a ref-
erence drug (Deng et al., 2010). In fact, an anxiolytic effect is
suggested when the drug increases the number of times the animal
enters into the open arms of the device without altering the total
number of arm entries. In treated mice, a signiﬁcant increase was
found both in the percentage of entries and in the percentage of
time spent in the open arms of the plus maze (Mora et al., 2005).
Therefore, the proﬁle of (+)-limonene was shown to be similar to
that of anxiolytic drugs. To investigate its possible mechanism of ac-
tion, ﬂumazenil, a benzodiazepine site antagonist was used. The phar-
macological effect of inhaled (+)-limonene (1%) was not blocked by
ﬂumazenil. These results suggest a non-benzodiazepine mechanism
in the anxiolytic-like activity of (+)-limonene, although the possibil-
ity of other GABAergic sites cannot be discarded. Additional studies,
therefore, are needed to fully clarify the mechanism of the
anxiolytic-like effect of (+)-limonene.
The sensation of smell induced by a substance can only be trig-
gered by a structural subunit. This site of interaction with a receptor
protein molecule results in a stimulus that is sent to the brain. The
volatility of the chemical components of essential oils allows their
interaction with chemoreceptors found in the olfactory system. The
set of molecules found in essential oils must interact with these
receptors. The pharmacological study of each molecule is important
in order to identify the volatile psychoactive substances and under-
stand the selectivity and afﬁnity of receptors to these molecules.0
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Fig. 2. Effect of (+)-limonene on the time spent on open (a) and closed (c) arms (s) and on the number of entries on open (b) and closed (d) arms in EPM test. Evaluation of different
concentrations of (+)-limonene by inhalation route (INH), ﬂumazenil and diazepam i.p. in male mice. Data are expressed as mean±SEM. N=8. **pb0.01, ***pb0.001 compared with
controls and, ###pb0.001 compared with diazepam. FLU = ﬂumazenil, DLO = (+) limonene, DZP = diazepam, INH = inhalation route, I.P. = intraperitoneal route.
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substance is high (IPCS, 1998). All the substances in this chemical
category are liquids at ambient temperature. The melting point of
(+)-limonene is reported to be−74.35 °C. The measured vapor pres-
sure value for (+)-limonene is 1.43 mm Hg or 0.19 kPa at 20 °C
(CRC, 2010). The concentration of this monoterpene in the sample
compartment increased over the course of time, with a concentration
of 7.56 μg/cm3 of air at 33 min.
The concentrations of (+)-limonene required to confer an anxio-
lytic effect are relatively low and the pure substance must be diluted.
Determination of (+)-limonene by GC–MS was carried out by intro-
ducing only 50 μL of pure (+)-limonene oil into the system. This
volume of 50 μL corresponds to 50 times less than the amount of
pure (+)-limonene oil that was required to distribute the substance
uniformly in cotton wool balls of 2 cm in diameter. The volume of
50 μL would be insufﬁcient to prevent bias in the content uniformity
of (+)-limonene made available inside the inhalation apparatus by
volatilization or to avoid bias resulting from the adsorption of traces
of (+)-limonene on the cotton balls. The decision to use Tween 80
to facilitate the solubility of (+)-limonene in water was based on
the application of this substance as a pharmaceutical adjuvant in
preparations for use in animals and humans.
Quantifying (+)-limonene by GC–MS permitted assessment of the
availability of the substance at the center of the experimental box. A
quantity of 50 μL of (+)-limonene, corresponding to 42.1 mg of the
substance used as a sample, was considered for the purpose of calcu-
lating the gas volume of 32 L or 0.032 m3. The concentration of
(+)-limonene per cm3 of air in the box was about 1.3 μg. The saline
solution containing 0.5% (+)-limonene embedded in each cotton
ball consisted of about 10.5 mg of the substance, making a total of
about 42 mg of (+)-limonene in the 4 balls of cotton wool. Therefore
the concentration of (+)-limonene as determined by GC–MS was
intended to simulate the values of (+)-limonene volatilized in the
cotton balls used in the experiments with the animals.
In addition, (+)-limonene is a hydrocarbonmonoterpene,which im-
plies that it must have high lipophilicity. This property may be relevant
for its pharmacological effect on account of a strong interaction withthe lipids of the cell membranes (Buchbauer et al., 1993). These data
show the potential clinical usefulness of (+)-limonene via inhalation.
The anxiolytic properties of some chemical constituents of essential
oils have already been demonstrated. In addition to linalool (Linck et al.,
2010), another monoterpene alcohol, isopulegol, was found to exert a
pharmacological effect on mice in the elevated plus maze and hole-
board tests (Silva et al., 2007). Monoterpenes from different chemical
classes also exhibit anxiolytic activity. For example, the phenol carva-
crol was effective in the elevated plus maze test and ﬂumazenil was
able to reverse its effects in mice (Melo et al., 2010). The monoterpene
ether 1,4-cineole was also psychoactive in the elevated plus maze and
hole-board tests. However, ﬂumazenil failed to reverse its effects in
mice, indicating that the anxiolytic effect of 1,4-cineole does not involve
benzodiazepine receptors (Gomes et al., 2010).
In a comparative analysis to study of the essential oil of C. aurantium
L. (Leite et al., 2008), our results showed that (+)-limonene has greater
pharmacological potency than this oil in the elevated plus-maze test. The
chromatographic analysis of the essential oil of C. aurantium L. showed
the presence of the characteristic components of this species, such
as alpha-pinene, sabinene, myrcene, linalool, decanal, and limonene
which was the major compound (96.24%). Meanwhile, the impurities
found in commercial limonene (97.00%) are mainly other monoter-
penes, such as myrcene, alpha-pinene, sabinene, and gamma-3-carene
(Karlberg and Lindell, 1993). These components may contribute to
the anxiolytic activity of (+)-limonene. In fact, there are reports of syn-
ergistic effects among some components of bioactive essential oils. For
example, it was demonstrated that themonoterpenes linalool and linalyl
acetate act synergistically in various species of Lavandula (4) that have
anxiolytic activity via inhalation (Takahashi et al., 2011). Therefore, addi-
tional studies are needed to investigate the possible contribution of the
impurities from commercial limonene on anxiolytic activity.
In summary, the present study shows that (+)-limonene adminis-
tered by inhalation exerted anxiolytic-like effects in the elevated plus
maze test and that this effect was not related to benzodiazepine re-
ceptors. These data indicate that (+)-limonene can be used as an an-
tianxiety agent in aromatherapy. Nonetheless, further studies should
be conducted to clarify the mechanism of its anxiolytic-like effects.
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